1. Home
  2. HGBL vs ZURA Comparison

HGBL vs ZURA Comparison

Compare HGBL & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HGBL
  • ZURA
  • Stock Information
  • Founded
  • HGBL 1937
  • ZURA 2022
  • Country
  • HGBL United States
  • ZURA United States
  • Employees
  • HGBL 86
  • ZURA N/A
  • Industry
  • HGBL Business Services
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • HGBL Consumer Discretionary
  • ZURA Health Care
  • Exchange
  • HGBL Nasdaq
  • ZURA Nasdaq
  • Market Cap
  • HGBL 66.7M
  • ZURA 69.9M
  • IPO Year
  • HGBL N/A
  • ZURA N/A
  • Fundamental
  • Price
  • HGBL $1.91
  • ZURA $1.68
  • Analyst Decision
  • HGBL Strong Buy
  • ZURA Buy
  • Analyst Count
  • HGBL 1
  • ZURA 7
  • Target Price
  • HGBL $4.00
  • ZURA $14.33
  • AVG Volume (30 Days)
  • HGBL 38.7K
  • ZURA 888.5K
  • Earning Date
  • HGBL 08-07-2025
  • ZURA 08-22-2025
  • Dividend Yield
  • HGBL N/A
  • ZURA N/A
  • EPS Growth
  • HGBL N/A
  • ZURA N/A
  • EPS
  • HGBL 0.10
  • ZURA N/A
  • Revenue
  • HGBL $48,940,000.00
  • ZURA N/A
  • Revenue This Year
  • HGBL $12.65
  • ZURA N/A
  • Revenue Next Year
  • HGBL $5.68
  • ZURA N/A
  • P/E Ratio
  • HGBL $19.78
  • ZURA N/A
  • Revenue Growth
  • HGBL N/A
  • ZURA N/A
  • 52 Week Low
  • HGBL $1.52
  • ZURA $0.97
  • 52 Week High
  • HGBL $2.39
  • ZURA $5.07
  • Technical
  • Relative Strength Index (RSI)
  • HGBL 36.29
  • ZURA 59.03
  • Support Level
  • HGBL $1.84
  • ZURA $1.44
  • Resistance Level
  • HGBL $2.20
  • ZURA $1.52
  • Average True Range (ATR)
  • HGBL 0.09
  • ZURA 0.12
  • MACD
  • HGBL -0.02
  • ZURA -0.01
  • Stochastic Oscillator
  • HGBL 30.56
  • ZURA 80.51

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: